DexCom and Insulet are not direct competitors in the sense that they manufacture the exact same product, but they are often categorized as key players in the same "ecosystem" of diabetes management. Insulet specializes in insulin delivery through its wearable pump systems (Omnipod), while DexCom is the industry leader in Continuous Glucose Monitoring (CGM) technology, which provides real-time glucose data. Their relationship is actually one of strategic integration; Insulet’s Omnipod 5 system integrates directly with DexCom’s CGM sensors to create an automated "closed-loop" insulin delivery system. While they both compete for the same overall share of a patient's diabetes management wallet, their relationship is more collaborative than adversarial, as the successful integration of their respective technologies is exactly what provides the most value to patients looking for automated, data-driven insulin management solutions.